Altium Capital Management LP Verastem, Inc. Transaction History

Altium Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$1.02 - $1.83 $49,980 - $89,670	49,000 Added 1.66%	3,000,000 $3.48 Million
Q1 2022 May 16, 2022	BUY	$1.06 - $2.1 $739,880 - $1.47 Million	698,000 Added 30.98%	2,951,000 $4.16 Million
Q3 2021 Nov 15, 2021	BUY	$2.54 - $4.07 $1.37 Million - $2.19 Million	537,411 Added 31.33%	2,253,000 $6.37 Million
Q2 2021 Aug 13, 2021	SELL	$2.57 - $4.85 $2.2 Million - $4.16 Million	-857,633 Reduced 33.33%	1,715,589 $6.98 Million
Q1 2021 May 06, 2021	SELL	$1.9 - $2.82 $301,628 - $447,680	-158,752 Reduced 5.81%	2,573,222 $6.36 Million
Q4 2020 Feb 16, 2021	BUY	$1.15 - $2.4 $3.14 Million - $6.56 Million	2,731,974 New	2,731,974 $5.82 Million

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $838M
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Altium Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Altium Capital Management LP with notifications on news.